Evidence map›Paper›PMID 41626126›Full record

ArticleAsia Oceania journal of nuclear medicine & biology2026

Peritoneal tuberculosis mimicking malignancy on FDG PET/CT in a patient with ankylosing spondylitis on adalimumab: a diagnostic challenge.

Harish Goyal, Srinivas Ananth Kumar, Anirudh Abu Srinivasan, Manikya Y S, Dhritiman Chakraborty

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Asia Oceania journal of nuclear medicine & biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Harish GoyalDepartment of Nuclear Medicine, Jawaharlal Institute of Postgraduate Medical Education Research, Puducherry, India.
Srinivas Ananth KumarDepartment of Nuclear Medicine, Jawaharlal Institute of Postgraduate Medical Education Research, Puducherry, India.
Anirudh Abu SrinivasanDepartment of Nuclear Medicine, Jawaharlal Institute of Postgraduate Medical Education Research, Puducherry, India.
Manikya Y SDepartment of Nuclear Medicine, Jawaharlal Institute of Postgraduate Medical Education Research, Puducherry, India.
Dhritiman ChakrabortyDepartment of Nuclear Medicine, Institute of Post Graduate Medical Education and Research, Kolkata, West Bengal, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor necrosis factor-alpha (TNF-α) inhibitors, such as adalimumab, are integral in the managing refractory ankylosing spondylitis (AS). However, their immunosuppressive effects elevate the risk of reactivation of latent tuberculosis (TB), especially extrapulmonary TB (EPTB), which can present with non-specific symptoms and mimic malignancy. We report the case of a 40-year-old man with ankylosing spondylitis who had been on long-term adalimumab therapy. He presented with a low-grade fever and weight loss. An

Indexed as

Ankylosing spondylitis AdalimumabExtrapulmonary tuberculosis 18F-FDG PET/CTPeritoneal tuberculosis Empirical therapy A B S T R A C T

Identifiers

PMID41626126
PMCPMC12854186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.